Drug therapy for acquired pendular nystagmus in multiple sclerosis

Journal of Neurology

Volumn 244, Issue 1, 1996, Pages 9-16

  Starck, M ^b   Albrecht, H ^b   Pollmann W ^b   Straube, A ^a   Dieterich, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Marianne Strauss Hospital   (Germany)

Author keywords

Acquired nystagmus; Drug therapy; Memantine; Multiple sclerosis; Scopolamine

Indexed keywords

GLUTAMATE RECEPTOR ANTAGONIST; MEMANTINE; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EYE FIXATION; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NYSTAGMUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION; VISUAL IMPAIRMENT;

EID: 0031060356     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00007728     Document Type: Article

References (40)

1. Aschoff JC, Conrad B, Kornhuber HH (1974) Acquired pendular nystagmus with oscillopsia in multiple sclerosis: a sign of cerebellar nuclei disease. J Neurol Neurosurg Psychiatry 37: 570-577
2. Averbuch-Heller I, Zivotofsky AZ, Das VE, DiScenna AO, Leigh RJ (1995) Investigations of the pathogenesis of acquired pendular nystagmus. Brain 118: 369-378
3. Barton JJS, Cox TA (1993) Acquired pendular nystagmus in multiple sclerosis: clinical observations and the role of optic neuropathy. J Neurol Neurosurg Psychiatry 56: 262-267
4. Barton JJS, Huaman AG, Sharpe JA (1994) Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs. Ann Neurol 35: 319-325
5. Bormann J (1989) Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 166: 591-592
6. Bubser M, Keseberg U, Notz PK, Schmidt WJ (1992) Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur J Pharmacol 229: 75-82
7. Castaigne P, Chain F, Pierrot-Deseiligny C, Larmande P (1979) Le nystagmus de circumduction monoculaire. Etude clinique, oculographique et electromyographique d'un cas, dans la sclerose en plaques. Rev Neurol (Paris) 135: 51-57
8. Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12: 4427-4436
9. Currie J, Matsuo V (1986) The use of clonazepam in the treatment of nystagmus induced oscillopsia. Ophthalmology 93: 924-932
10. Danneberg PB, Shelley JH (1977) The pharmacology of mexiletine. Postgrad Med J 53 [Suppl 1]: 25-29
11. Dieterich M, Straube A, Brandt T, Paulus W, Büttner U (1991) The effects of baclofen and anticholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry 54: 627-632
12. Ell JJ, Gresty MA, Chambers BR, Findley LJ (1982) Acquired pendular nystagmus: characteristics, pathophysiology and pharmacological modification. In: Roucoux A, Crommelinck M (eds) Physiological and pathological aspects of eye movements. Junk, The Hague, pp 89-98
13. Gresty MA, Ell JJ, Findley LJ (1982) Acquired pendular nystagmus: its characteristics, localizing value and pathophysiology. J Neurol Neurosurg Psychiatry 45: 431-439
14. Helveston EM, Pogrebniak AE (1988) Treatment of acquired nystagmus with botulinum toxin A. Am J Ophthalmol 106: 584-586
15. Helveston EM, Ellis FD, Plager DA (1991) Large recession of the horizontal recti for treatment of nystagmus. Ophthalmology 98: 1302-1305
16. Herishanu Y, Louzoun Z (1986) Trihexyphenidyl treatment of vertical pendular nystagmus. Neurology 36: 82-84
17. Ito M (1984) Glutamate as a neurotransmitter in the cerebellar cortex. Biomed Res 5 [Suppl]: 63-66
18. Jabbari B, Rosenberg M, Scherokman B, Gunderson C, McBurney JW, McClintock W (1987) Effectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction. Mov Disord 2: 93-98
19. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452
20. Lefkowitz D, Harpold G (1985) Treatment of ocular myoclonus with valproic acid. Ann Neurol 17: 103-104
21. Leigh RJ, Zee DS (1991) The neurology of eye movements, 2nd edn. Davis, Philadelphia
22. Leigh RJ, Rushton DN, Thurston SE, Hertle RW, Yaniglos SS (1988) Effects of retinal image stabilization in acquired nystagmus due to neurologic disease. Neurology 38: 122-127
23. Leigh RJ, Burnstine TH, Ruff RL, Kasmer RJ (1991) The effect of anticholinergic agents upon acquired nystagmus: a double-blind study of trihexyphenidyl and tridihexethyl chloride. Neurology 41: 1737-1741
24. Leigh RJ, Tomsak RL, Grant MP, Remler BF, Yaniglos SS, Lystad L, Dell'Osso LF (1992) Effectiveness of botulinum toxin administered to abolish acquired nystagmus. Ann Neurol 32: 633-642
25. Leigh RJ, Averbuch-Heller L, Tomsak RL, Remler BF, Yuniglos SS, Dell'Osso LF (1994) Treatment of abnormal eye movements that impair vision: strategies based on current concepts of physiology and pharmacology. Ann Neurol 36: 129-141
26. Llinas R, Yarom Y (1986) Oscillatory properties of guinea pig interior olivary neurones and their pharmacological modulations: an in vitro study. J Physiol (Lond) 236: 163-182
27. Matsuo F, Ajax E (1979) Palatal myoclonus and denervation supersensitivity in the central nervous system. Ann Neurol 5: 72-78
28. Mossman SS, Bronstein AM, Rudge P, Gresty MA (1985) Acquired pendular nystagmus suppressed by alcohol. Neuroophthalmology 13: 99-106
29. Mugnaini E, Oertel W (1985) An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy, vol 4. GABA and neuropeptides in the CNS, part I. Elsevier, Amsterdam, pp 436-608
30. Nathanson M, Bergman PS, Bender MB (1953) Visual disturbances as the result of nystagmus on direct forward gaze: effect of sodium amytal. Arch Neurol Psychiatry 69: 427-435
31. Pellegrini JW, Lipton SA (1993) Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol 33: 403-407
32. Poser CM, Paty DW, Scheinberg LC, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231
33. Robinson FR, Straube A, Fuchs AF (1993) Role of the caudal fastigial nucleus in saccade generation. II. Effects of muscimol inactivation. J Neurophysiol 70: 1741-1758
34. Rosenmund C, Legendre P, Westbrook GL (1992) Expression of NMDA channels on cerebellar Purkinje cells acutely dissociated from newborn rats. J Neurophysiol 68: 1901-1905
35. Ross CA, Bredt D, Snyder SH (1990) Messenger molecules in the cerebellum. Trends Neurosci 13: 216-222
36. Straube A, Büttner U (1991) Medikamentöse Therapie supranukleärer Augenbewegungsstörungen. Nervenarzt 62: 212-220
37. Straube A, Paulus W, Quintern J, Brandt T (1989) Visual ataxia induced by eye movements: posturographic measurements in normals and patients with ocular motor disorders. Clin Sci 4: 107-113
38. Tahmoush A, Brooks JE, Keltner JL (1972). Palatal myoclonus associated with abnormal ocular and extremity movements. Arch Neurol 27: 431-440
39. Traccis S, Rosati G, Monaco M, Aiello I, Agnetti V (1990) Successful treatment of acquired pendular elliptical nystagmus in multiple sclerosis with isoniazid and base-out prisms. Neurology 40: 492-494
40. Yokota T, Tsukagoshi H (1991) Olivary hypertrophy precedes the appearance of palatal myoclonus. J Neurol 238: 408